Additional information

Contraception is a method which prevents one from getting an unwanted pregnancy. Every month the ovaries produce an egg. The semen which is released when a man ejaculates contains millions of sperm. It takes only one of this sperm from the semen to fertilise one of the eggs to begin a pregnancy. The use of contraception methods helps to reduce the risk of getting pregnant.

The Middle East & Africa contraceptive devices market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include increasing the incidence of the sexually transmitted diseases (STDs), increasing government initiatives and private firms to prevent unwanted abortions and pregnancies, high unmet contraceptive needs in developing economies, increasing population globally, effective contraception and fewer side effects of IUCDs, and conceivable non-contraception health benefits. However, stringent regulations and reimbursement policies, religious and cultural opposition towards contraceptive methods, the high cost of the treatment, constrained access in developing economies, and lack of awareness are thereby hindering the market growth. Various challenges of the contraceptive market include several concerns about side effects and increasing elderly population pool and rise in infertility prevalence.

If a person is not using a contraceptive or incorrect use can result in an unintended pregnancy. The percentage of unintended pregnancies is higher among the teens younger than 18 years, followed by the age group of 20-24 years. However, from the past few years, the awareness on contraception has contributed to both fall in unwanted pregnancies and also growth in the usage of the contraceptives market.

The Middle East & Africa Contraceptive Devices Market Segments Share:

The Middle East & Africa, contraceptive devices market, is categorised into a type which comprises of condoms, diaphragms, cervical caps, sponges, vaginal rings, IUD, and implants. Among them, condoms segment is projected to hold the largest share in the market. Inexpensive, readily accessible, convenient, and no delay in fertility after their use are some of the benefits of using a condom. IUD segment is projected to witness the highest growth rate during the forecast period, and it is trustable, effective and is mainly used by women. By gender, the market is segmented into male and female. By end-users, the market is segmented into hospitals, homecare, gynaecology centres, clinics, ambulatory surgical centres (ASC), and others.

By Geography, Middle East is projected to hold the largest share in the market due to the rising incidence of unintended pregnancies, and increased use of contraceptive devices. However, Africa is projected to be the fastest growing market due to growing awareness among people, increased incidence of unintended pregnancies & sexually transmitted diseases and several government initiatives. Favourable family planning policy along with other reimbursement policies such as the AIDS care policy will positively impact the growth of the market.

The Middle East & Africa Contraceptive Devices Market Trends:

Afaxys, Inc. and Bayer healthcare company announced that they are going to ally to expand access to contraception in the public health sector.

The new developments in IUD’s technology are that smaller frameless copper and levonorgestrel-releasing devices are trying to help, increase the prevalence of use in adolescents and nulliparous women.

The Middle East & Africa Contraceptive Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

Bayer Healthcare Pharmaceuticals

Merck & Co., Inc.

Pfizer, Inc.

Johnson & Johnson, Ltd

Reckitt Benckiser Plc

Along with these companies, there were many other companies considered/cited in the report while analysing the Middle East & Africa contraceptives device market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.

Contraception is a method which prevents one from getting an unwanted pregnancy. Every month the ovaries produce an egg. The semen which is released when a man ejaculates contains millions of sperm. It takes only one of this sperm from the semen to fertilise one of the eggs to begin a pregnancy. The use of contraception methods helps to reduce the risk of getting pregnant.

The Middle East & Africa contraceptive devices market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include increasing the incidence of the sexually transmitted diseases (STDs), increasing government initiatives and private firms to prevent unwanted abortions and pregnancies, high unmet contraceptive needs in developing economies, increasing population globally, effective contraception and fewer side effects of IUCDs, and conceivable non-contraception health benefits. However, stringent regulations and reimbursement policies, religious and cultural opposition towards contraceptive methods, the high cost of the treatment, constrained access in developing economies, and lack of awareness are thereby hindering the market growth. Various challenges of the contraceptive market include several concerns about side effects and increasing elderly population pool and rise in infertility prevalence.

If a person is not using a contraceptive or incorrect use can result in an unintended pregnancy. The percentage of unintended pregnancies is higher among the teens younger than 18 years, followed by the age group of 20-24 years. However, from the past few years, the awareness on contraception has contributed to both fall in unwanted pregnancies and also growth in the usage of the contraceptives market.

The Middle East & Africa Contraceptive Devices Market Segments Share:

The Middle East & Africa, contraceptive devices market, is categorised into a type which comprises of condoms, diaphragms, cervical caps, sponges, vaginal rings, IUD, and implants. Among them, condoms segment is projected to hold the largest share in the market. Inexpensive, readily accessible, convenient, and no delay in fertility after their use are some of the benefits of using a condom. IUD segment is projected to witness the highest growth rate during the forecast period, and it is trustable, effective and is mainly used by women. By gender, the market is segmented into male and female. By end-users, the market is segmented into hospitals, homecare, gynaecology centres, clinics, ambulatory surgical centres (ASC), and others.

By Geography, Middle East is projected to hold the largest share in the market due to the rising incidence of unintended pregnancies, and increased use of contraceptive devices. However, Africa is projected to be the fastest growing market due to growing awareness among people, increased incidence of unintended pregnancies & sexually transmitted diseases and several government initiatives. Favourable family planning policy along with other reimbursement policies such as the AIDS care policy will positively impact the growth of the market.

The Middle East & Africa Contraceptive Devices Market Trends:

Afaxys, Inc. and Bayer healthcare company announced that they are going to ally to expand access to contraception in the public health sector.

The new developments in IUD’s technology are that smaller frameless copper and levonorgestrel-releasing devices are trying to help, increase the prevalence of use in adolescents and nulliparous women.

The Middle East & Africa Contraceptive Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

Bayer Healthcare Pharmaceuticals

Merck & Co., Inc.

Pfizer, Inc.

Johnson & Johnson, Ltd

Reckitt Benckiser Plc

Along with these companies, there were many other companies considered/cited in the report while analysing the Middle East & Africa contraceptives device market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.

Envision Inteligence is the Main Supplier of Market Analysis Reviews, Customized Consulting Companies, Information Analytics and Trade Evaluation. Our purpose is to offer the correct data required by the stakeholder on the proper level of time.Read More